Synaptogenix Inc.

NASDAQ: SNPX · Real-Time Price · USD
7.85
1.80 (29.86%)
At close: Jun 30, 2025, 3:59 PM

Synaptogenix Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
17.66M 28.66M 37.48M 34.21M
Short-Term Investments
n/a 1.44M n/a n/a
Long-Term Investments
n/a 562.4K n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
64.63K 57.68K 739.47K 0.00
Total Current Assets
17.72M 30.53M 38.59M 35.5M
Property-Plant & Equipment
12.93K 18.5K 22.14K 20.45K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
12.93K 580.91K 22.14K 20.45K
Total Assets
17.73M 31.11M 38.61M 35.52M
Account Payables
317.29K 444.63K 660.21K 1.3M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
696.98B 3.4M 115.89K n/a
Total Current Liabilities
1,014.3B 4.28M 1.31M 1.99M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
9.94M 1.25M 1.88M n/a
Total Long-Term Liabilities
9.94M 1.25M 1.88M n/a
Total Liabilities
10.96M 5.53M 3.19M 1.99M
Total Debt
n/a n/a n/a n/a
Common Stock
137.00 2.41K 728.00 674.00
Retained Earnings
-47,169.2B -33.61M -19.83M -14.14M
Comprehensive Income
5.7K 902.00 0.00 0.00
Shareholders Equity
5,863.7B 25.58M 35.41M 33.53M
Total Investments
17,656.2B 2M n/a n/a